Latest Posts



Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More


Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Bio DataWorld 2022

BioTechX successfully brings together an amalgamation of genomics, translational medicine, data scientists, IT, bioinformaticians, cheminformaticians, clinicians, healthcare and pharma companies. The event will showcase innovation, demonstrate success and break through the obstacles and barriers to ensure that the innovations in genomics and big data, enter the clinic with speed and efficiency.

Join us and be part of the story in 2022 with 400 speakers and 2,000+ attendees.


– Dr. Andreas Hochheimer – Chief Science Officer, Innoplexus AG

– Ph.D. Om Prakash Sharma – VP Bioinformatics, Innoplexus AG

– Mr. Vatsal Agarwal – SVP Real World Data & Analytics, Innoplexus AG

– Mr. Oliver Bayliss – Global Business Development Lead, Innoplexus AG

– Ms. Claudia M. Hausoel – Chief Marketing Officer, Innoplexus AG

Date: November 08-10, 2022

Venue Partner: Congress Center, Basel Switzerland

Read more

BioDataWorld 2022